Skip to content
Vistagen Therapeutics Inc icon

Vistagen Therapeutics Inc

VTGNStocksBiotechnologyUnited StatesNasdaqUSD

Price

$0.27

Today

-8.5%

YTD

-54.1%

About

Vistagen Therapeutics, Inc. is a biopharmaceutical entity in the study of mental wellbeing. Operating in the US, Vistagen aims to help with mental health issues worldwide such as depressive and anxiety disorders. In the bustling biotechnology sector, Vistagen Therapeutics delves into transdisciplinary studies to assist mental health issues. As a stand-alone organisation, Vistagen uses techniques to develop medications that fill the gaps left by traditional treatments for depression and anxiety disorders. Vistagen has a vast array of programs focused on anxiety, depression, suicidal ideation, and neuropathic pain. Learn more about the share price performance of VTGN on eToro.

Price chart
Closing price history for VTGN (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-0.14
P/S (TTM)8.05
P/B (TTM)0.29
Market cap$10.59M
Cap tierMicro-cap
Industry avg P/E-6.21

Profitability

Gross margin42.28%
EBIT margin-5678.74%
Net margin-3499.78%
ROE-46.28%
ROA-42.35%

Earnings & Revenue

Revenue (TTM)$1.27M
Revenue growth (1Y)-33.0%
EPS (TTM)-$1.87
Free cash flow$-66.59M
Total debt$1.04M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.71
Employees41
Next earnings12 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Vistagen Therapeutics Inc (VTGN) | Dirk Kuyken